akash.verma@cenmed.com
(732) 447-1115-
MABX8404-1MGGeneral description This human recombinant monoclonal Anti-SARS-CoV-2 Nucleocaspid humanized, clone 4D8, Cat. No. -
MABX8406-10MGGeneral description This human recombinant monoclonal Anti-SARS-CoV-2 N humanized antibody (5B7), Cat. No. -
MABX8406-1MGGeneral description This human recombinant monoclonal Anti-SARS-CoV-2 N humanized antibody (5B7), Cat. No. -
MABX8407-10MGGeneral description This mouse monoclonal Anti-SARS-CoV-2 N mouse antibody (7B3), Cat. No. -
MABX8407-1MGGeneral description This mouse monoclonal Anti-SARS-CoV-2 N mouse antibody (7B3), Cat. No. -
PHL85759-10MGGeneral description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. -
![[sar9]-substance p (c15-1727-365)](https://cdn11.bigcommerce.com/s-fbnjghndiq/images/stencil/500x659/products/1726149/1807608/cenmed-product-image-placeholder-1-__12986.1732995285.jpg?c=1 "[sar9]-substance p (c15-1727-365)")
SCP0244-1MGAmino Acid Sequence Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH2 Application Substance P is a tachykinin family 11 amino acid neuropeptide involved in neurotransmission and neuromodulation. Substance P acts via the neurokinin-1 receptor -
![[sar9]-substance p (c15-1727-364)](https://cdn11.bigcommerce.com/s-fbnjghndiq/images/stencil/500x659/products/1726148/1807607/cenmed-product-image-placeholder-1-__11113.1732995285.jpg?c=1 "[sar9]-substance p (c15-1727-364)")
SCP0244-5MGAmino Acid Sequence Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH2 Application Substance P is a tachykinin family 11 amino acid neuropeptide involved in neurotransmission and neuromodulation. Substance P acts via the neurokinin-1 receptor -
SML1343-25MGApplication 3PO has been used as a 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3(PFKFB3) inhibitor to study its effect on cell viability loss, apoptosis, and necroptosis in colorectal cancer cells. It has also been used as a -
SML1343-5MGApplication 3PO has been used as a 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3(PFKFB3) inhibitor to study its effect on cell viability loss, apoptosis, and necroptosis in colorectal cancer cells. It has also been used as a -
SML1509-25MGBiochem/physiol Actions MK6-83 is a potent activator of wild type and mutant variants F465L and F408D of TRPML1 channel. MK6-83 weakly activates TRPML mutants R403C or V446L. -
SML1509-5MGBiochem/physiol Actions MK6-83 is a potent activator of wild type and mutant variants F465L and F408D of TRPML1 channel. MK6-83 weakly activates TRPML mutants R403C or V446L.
